Nirvan Mullick

I went to see my son’s school project, and left knowing there was a bigger story to tell @FOX4 . #CardboardChallenge inspires @RichardsonISD students @canyoncreekrisd Thank you @IamBranum @CainesArcade @nirvan @2BitFoundation

This video debunks serious flaws and mis-information in the @FDA Advisory Committee hearing (that recommended against approving MDMA Therapy to treat PTSD) and exposes how a small group of radical anti-capitalist activists called Psymposia hijacked a federal regulatory process. With the FDA poised to determine whether to approve MDMA therapy or not, this coordinated mis-information campaign by a small group of activists and ICER may derail a life saving treatment for millions. Here is how it happened: 1. Psymposia made unverified and sensationalized accusations to portray @Lykos_PBC trial data as systemically flawed. 2. Their unverified claims were then repeated by @ICER_review in a questionable report that was not fact checked, and published before the June 4th AdComm meeting. ICER is a group that helps set drug prices for the insurance and health care industry. Psymposia's unverified accusations of researcher bias, study flaws, and systemic omissions published in the ICER report were then amplified by major media outlets like @NPR and the @NYtimes. This misinformation then derailed the FDA Advisory Committee. Because of the way the hearing was structured, the trial sponsor, Lykos, was not given time to correct the myriad of misinformation discussed by the panel for several hours before the panel voted. The panel voted almost unanimously against recommending approval. The resulting press has created an inaccurate cloud of confusion casting doubt on the science and efficacy of the treatment. Fortunately, the committee's vote is non-binding. Lets urge the FDA to follow the science. #approveMDMAtherapy #MDMA4PTSD film by @nirvan featuring @laurentaus editing @umuima produced by @interconnectd @dreammullick

This video debunks serious flaws and mis-information in the @FDA Advisory Committee hearing (that recommended against approving MDMA Therapy to treat PTSD) and exposes how a small group of radical anti-capitalist activists called Psymposia hijacked a federal regulatory process. With the FDA poised to determine whether to approve MDMA therapy or not, this coordinated mis-information campaign by a small group of activists and ICER may derail a life saving treatment for millions. Here is how it happened: 1. Psymposia made unverified and sensationalized accusations to portray @Lykos_PBC trial data as systemically flawed. 2. Their unverified claims were then repeated by @ICER_review in a questionable report that was not fact checked, and published before the June 4th AdComm meeting. ICER is a group that helps set drug prices for the insurance and health care industry. Psymposia's unverified accusations of researcher bias, study flaws, and systemic omissions published in the ICER report were then amplified by major media outlets like @NPR and the @NYtimes. This misinformation then derailed the FDA Advisory Committee. Because of the way the hearing was structured, the trial sponsor, Lykos, was not given time to correct the myriad of misinformation discussed by the panel for several hours before the panel voted. The panel voted almost unanimously against recommending approval. The resulting press has created an inaccurate cloud of confusion casting doubt on the science and efficacy of the treatment. Fortunately, the committee's vote is non-binding. Lets urge the FDA to follow the science. #approveMDMAtherapy #MDMA4PTSD film by @nirvan featuring @laurentaus editing @umuima produced by @interconnectd @dreammullick